Cargando…
Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications
Human immunodeficiency virus (HIV) infection is a major problem for humanity because HIV is constantly changing and developing resistance to current drugs. This necessitates the development of new anti-HIV drugs that take new approaches to combat an ever-evolving virus. One of the promising alternat...
Autores principales: | Liman, Wissal, Ait Lahcen, Nouhaila, Oubahmane, Mehdi, Hdoufane, Ismail, Cherqaoui, Driss, Daoud, Rachid, El Allali, Achraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502546/ https://www.ncbi.nlm.nih.gov/pubmed/36145313 http://dx.doi.org/10.3390/ph15091092 |
Ejemplares similares
-
Monte Carlo Method and GA-MLR-Based QSAR Modeling of NS5A Inhibitors against the Hepatitis C Virus
por: Liman, Wissal, et al.
Publicado: (2022) -
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
por: Oubahmane, Mehdi, et al.
Publicado: (2023) -
COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2
por: Oubahmane, Mehdi, et al.
Publicado: (2021) -
In Silico SAR Studies of HIV-1 Inhibitors
por: Hdoufane, Ismail, et al.
Publicado: (2018) -
In silico protein engineering shows that novel mutations affecting NAD(+) binding sites may improve phosphite dehydrogenase stability and activity
por: Baammi, Soukayna, et al.
Publicado: (2023)